Clinically unrecognized Q-wave mycocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy

被引：18

作者：

Aguilar, D

Goldhaber, SZ

Gans, DJ

Levey, AS

Porush, JG

Lewis, JB

Rouleau, JL

Berl, T

Lewis, EJ

Pfeffer, MA

机构：

[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA

[2] Bristol Myers Squibb Pharmaceut Res Inst, Pennington, NJ USA

[3] Tufts Univ New England Med Ctr, Boston, MA USA

[4] Brookdale Univ Hosp, Brooklyn, NY USA

[5] Ctr Med, Brooklyn, NY USA

[6] Vanderbilt Univ, Coll Med, Nashville, TN USA

[7] Univ Montreal, Montreal, PQ, Canada

[8] Univ Colorado, Sch Med, Denver, CO 80202 USA

[9] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA

[10] Univ Texas, Hlth Sci Ctr, Div Cardiol, Houston, TX USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 94卷 / 03期

关键词：

D O I：

10.1016/j.amjcard.2004.04.028

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

During the Irbesartan Diabetic Nephropathy Trial, 1,387 participants with type 2 diabetes mellitus, hypertension, and nephropathy underwent serial electrocardiograms for the identification of Q-wave myocardial infarction (MI). During a mean follow-up of 2.5 years, 14 of 99 first nonfatal MIs in this group were clinically unrecognized, accounting for 14% of all first nonfatal MIs. (C) 2004 by Excerpta Medica, Inc.

引用

收藏

页码：337 / 339

页数：3

相关论文

共 17 条

[1] Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy [J].

Berl, T ;

Hunsicker, LG ;

Lewis, JB ;

Pfeffer, MA ;

Porush, JG ;

Rouleau, JL ;

Drury, PL ;

Esmatjes, E ;

Hricik, D ;

Parikh, CR ;

Raz, I ;

Vanhille, P ;

Wiegmann, TB ;

Wolfe, BM ;

Locatelli, F ;

Goldhaber, SZ ;

Lewis, EJ .

ANNALS OF INTERNAL MEDICINE, 2003, 138 (07) :542-549

[2] Occurrence of unrecognized myocardial infarction in subjects aged 45 to 65 years (The ARIC study) [J].

Boland, LL ;

Folsom, AR ;

Sorlie, PD ;

Taylor, HA ;

Rosamond, WD ;

Chambless, LE ;

Cooper, LS .

AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (09) :927-931

[3] Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with, diabetes mellitus and no known coronary artery disease [J].

De Lorenzo, A ;

Lima, RSL ;

Siqueira, AG ;

Pantoja, MR .

AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (08) :827-832

[4] Prevalence, determinants, and misclassification of myocardial infarction in the elderly [J].

deBruyne, MC ;

Mosterd, A ;

Hoes, AW ;

Kors, JA ;

Kruijssen, DACM ;

vanBemmel, JH ;

Hofman, A ;

Grobbee, DE .

EPIDEMIOLOGY, 1997, 8 (05) :495-500

[5] Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals [J].

Gerstein, HC ;

Mann, JFE ;

Yi, QL ;

Zinman, B ;

Dinneen, SF ;

Hoogwerf, B ;

Hallé, JP ;

Young, J ;

Rashkow, A ;

Joyce, C ;

Nawaz, S ;

Yusuf, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (04) :421-426

[6]

GRIMM RH, 1987, CIRCULATION, V75, P6

[7] Incidence and prevalence of recognised and unrecognised myocardial infarction in women - The Reykjavik Study [J].

Jonsdottir, LS ;

Sigfusson, N ;

Sigvaldason, H ;

Thorgeirsson, G .

EUROPEAN HEART JOURNAL, 1998, 19 (07) :1011-1018

[8] INCIDENCE AND PROGNOSIS OF UNRECOGNIZED MYOCARDIAL-INFARCTION - AN UPDATE ON THE FRAMINGHAM-STUDY [J].

KANNEL, WB ;

ABBOTT, RD .

NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (18) :1144-1147

[9] Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].

Lewis, EJ ;

Hunsicker, LG ;

Clarke, WR ;

Berl, T ;

Pohl, MA ;

Lewis, JB ;

Ritz, E ;

Atkins, RC ;

Rohde, R ;

Raz, I .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860

[10] UNRECOGNIZED MYOCARDIAL-INFARCTION - 5-YEAR INCIDENCE, MORTALITY, AND RISK-FACTORS [J].

MEDALIE, JH ;

GOLDBOURT, U .

ANNALS OF INTERNAL MEDICINE, 1976, 84 (05) :526-531